ZELLI, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.742
EU - Europa 1.436
AS - Asia 1.074
SA - Sud America 263
Continente sconosciuto - Info sul continente non disponibili 86
AF - Africa 35
OC - Oceania 4
Totale 5.640
Nazione #
US - Stati Uniti d'America 2.653
SG - Singapore 498
RU - Federazione Russa 397
IT - Italia 339
IE - Irlanda 237
BR - Brasile 221
HK - Hong Kong 156
DE - Germania 148
CN - Cina 137
VN - Vietnam 137
FI - Finlandia 73
CA - Canada 45
GB - Regno Unito 39
BD - Bangladesh 33
SE - Svezia 32
FR - Francia 31
CZ - Repubblica Ceca 25
IN - India 25
JP - Giappone 20
ES - Italia 18
PL - Polonia 18
ZA - Sudafrica 18
LT - Lituania 17
BE - Belgio 14
MX - Messico 14
AR - Argentina 12
UA - Ucraina 10
EC - Ecuador 9
VE - Venezuela 8
ID - Indonesia 7
IQ - Iraq 7
NL - Olanda 7
CO - Colombia 6
PH - Filippine 6
TR - Turchia 6
UY - Uruguay 6
CR - Costa Rica 5
KR - Corea 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
IL - Israele 4
SV - El Salvador 4
UZ - Uzbekistan 4
AU - Australia 3
DZ - Algeria 3
EG - Egitto 3
GP - Guadalupe 3
GT - Guatemala 3
HN - Honduras 3
KE - Kenya 3
NP - Nepal 3
PT - Portogallo 3
BA - Bosnia-Erzegovina 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
MA - Marocco 2
NI - Nicaragua 2
NO - Norvegia 2
PK - Pakistan 2
PR - Porto Rico 2
RO - Romania 2
SN - Senegal 2
TN - Tunisia 2
AL - Albania 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
CH - Svizzera 1
GI - Gibilterra 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MQ - Martinica 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 5.556
Città #
Dallas 423
San Jose 337
Singapore 283
Ashburn 267
Dublin 235
Chandler 233
Hong Kong 153
Council Bluffs 137
Santa Clara 117
New York 80
The Dalles 70
Munich 69
Boardman 68
Jacksonville 60
Los Angeles 58
Moscow 55
L’Aquila 47
Milan 38
Rome 36
Ho Chi Minh City 35
Hanoi 33
Helsinki 32
São Paulo 31
Beijing 30
Princeton 29
Lawrence 28
Turku 26
Brno 23
Columbus 22
Wilmington 21
Bremen 20
Des Moines 20
Kitzingen 20
San Mateo 19
Tokyo 19
Frankfurt am Main 18
Teramo 18
Warsaw 17
Lappeenranta 15
Brussels 14
Lauterbourg 14
Casoria 13
Johannesburg 13
Phoenix 13
Stockholm 13
Vilnius 13
Chennai 12
Orem 12
Atlanta 11
Toronto 11
Chicago 10
Montreal 10
Brooklyn 9
Da Nang 9
Fremont 9
Naples 9
Turin 9
Assago 8
Denver 8
London 8
Miano 8
North Bergen 8
San Francisco 8
Ann Arbor 7
Falkenstein 7
Norwalk 7
Shanghai 7
Woodbridge 7
Boston 6
Dong Ket 6
Haiphong 6
Manchester 6
Mexico City 6
Montevideo 6
Poplar 6
Campinas 5
Jakarta 5
Porto Alegre 5
Recife 5
Washington 5
Amsterdam 4
Assisi 4
Curitiba 4
Edinburgh 4
Fortaleza 4
Houston 4
Manila 4
Miami 4
Newark 4
Nuremberg 4
Padua 4
Perugia 4
Providence 4
Queens 4
San José 4
Seoul 4
Sofia 4
Tashkent 4
Ankara 3
Austin 3
Totale 3.674
Nome #
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 175
Concurrent RAS and RAS/BRAF V600E variants in colorectal cancer: more frequent than expected? 174
MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression 169
MicroRNAs Expression in Response to rhNGF in Epithelial Corneal Cells: Focus on Neurotrophin Signaling Pathway 168
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status. 165
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 164
Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma 163
A TaqMan-Based qRT-PCR Assay for Accurate Evaluation of the Oncogenic TrkAIII Splice Variant in Tumor cDNAs 162
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer 160
Emerging role of isomirs in cancer: State of the art and recent advances 159
Circulating micrornas as prognostic and therapeutic biomarkers in breast cancer molecular subtypes 151
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells 144
Classification of tumor types using XGBoost machine learning model: a vector space transformation of genomic alterations 143
Contribution of MUTYH variants to male breast cancer risk: results from a multicenter study in Italy 142
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells 139
MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment 138
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression 136
General Direct Anticancer Effects of Deer Growing Antler Extract in Several Tumour Cell Lines, and Immune System-Mediated Effects in Xenograft Glioblastoma 127
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting 125
A method to comprehensively identify germline SNVs, INDELs and CNVs from whole exome sequencing data of BRCA1/2 negative breast cancer patients 124
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood 119
Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer 119
Ultrasound as a New Method for the Release and Identification of Novel microRNAs and Proteins as Candidate Biomarkers in Pancreatic Cancer 117
Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemia/reperfusion model 115
Role of Circulating microRNAs in Liver Disease and HCC: Focus on miR-122 112
449: Gene-specific methylation profiles in male breast cancer 112
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores 110
A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy 103
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene 100
A TAQMAN-BASED QRT-PCR ASSAY FOR DETECTING TRKAIII EXPRESSION IN TUMOR TISSUE RNAS 99
The TrkAIII splice variant oncoprotein enhances PD-L1 expression in human SH-SY5Y neuroblastoma cells 99
Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers 99
The antiquity of hydrocephalus: the first full palaeo-neuropathological description 98
Proffered papers and posters presented at the Sixth International Symposium on Hereditary Breast and Ovarian Cancer— BRCA: Challenges and Opportunities 94
Methylome profiling of BRCA-positive and BRCA-negative MBCs 91
Metastases risk in thin cutaneous melanoma: Prognostic value of clinical-pathologic characteristics and mutation profile 90
Insight into genetic susceptibility to male breast cancer by multigene panel testing: results from a multicenter study in Italy 90
MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas 90
CD44 mRNA expression in hormonally treated and non-treated prostate cancer cases 87
Smoking and FGFR2 rs2981582 variant independently modulate male breast cancer survival: A population-based study in Tuscany, Italy 83
Transcriptome of male breast cancer matched with germline profiling reveals novel molecular subtypes with possible clinical relevance 82
TRKAIII PROMOTES PD-L1 EXPRESSION IN SH-SY5Y NEUROBLASTOMA CELLS 82
EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations 81
Evaluation of cyp17a1 and cyp1b1 polymorphisms in male breast cancer risk 79
Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: Results from a multicenter study in Italy 75
PIK3CA c.3140A>G mutation in a patient with suspected Proteus Syndrome: a case report 74
Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers 65
Anthracycline-Free Neoadjuvant Pertuzumab-Trastuzumab-Taxane in Patients with HER2-Positive Early Breast Cancer: Hormone Receptor Status as a Key Determinant of Pathological Complete Response 24
Effect of Osteoblast-Derived Extracellular Vesicles on Osteosarcoma Cells’ Transcriptional Profile: Role of Shuttled miRNAs 18
null 5
Totale 5.640
Categoria #
all - tutte 23.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.853


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022139 0 0 0 1 24 1 5 8 13 3 9 75
2022/2023685 38 52 18 76 48 81 3 39 281 3 37 9
2023/2024281 19 9 21 7 13 79 1 37 2 18 9 66
2024/20251.144 34 23 74 55 128 93 156 130 151 104 111 85
2025/20262.596 136 235 387 303 260 120 325 80 224 357 102 67
2026/2027655 65 66 134 390 0 0 0 0 0 0 0 0
Totale 5.640